Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy MYGN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Myriad Genetics (MYGN)

@ 4:00 PM
Click the portfolio to add MYGN:
Close [X]
+ Add MYGN to Portfolio
  
  Last Trade: $23.37 -0.21 (-0.89%)
  Volume: 419,198 64% of avg daily volume
       
  Avg Volume: 659,948
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 23.12 - 23.51
  Open: 23.49
  Previous Close: 23.58
  52-wk Range: 17.51 - 25.89
  Market Cap: 2.0B
  P/E: 19.3
  Div Yield: $0.00 (0.00%)
Indexes
Cancer Stocks (-0.9%)
Genetic Analysis Sto... (-0.1%)
Spy MYGN

? Pro holders
? Member holders
? Items submitted
Additional MYGN resources



Customize Links
To see which Pros and tickerspy members own MYGN Sign up now
Latest MYGN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference
MYGN  
Linked by GlobeNewswire - February 06, 04:15PM from (www.globenewswire.com)
SALT LAKE CITY, Feb. 6, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Jim Evans, Chief  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad's Prolaris(R) Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy
MYGN  
Linked by GlobeNewswire - February 02, 04:05PM from (www.globenewswire.com)
SALT LAKE CITY, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics Reports Second Quarter Fiscal Year 2012 Results
MYGN  
Linked by GlobeNewswire - January 31, 04:05PM from (www.globenewswire.com)
SALT LAKE CITY, Jan. 31, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its second  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Will Roche's Takeover Bid Help People Predict Diseases?
MYGN  ILMN  
Linked by Benzinga.com - January 25, 12:39PM from (www.benzinga.com)
Today, pharmaceutical giant Roche announced a hostile takeover bid for Illumina (NASDAQ: ILMN) worth $5.7 billion in cash,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics Acquires Exclusive Rights to RAD51C Gene
MYGN  
Linked by GlobeNewswire - January 18, 04:10PM from (www.globenewswire.com)
SALT LAKE CITY, Jan. 18, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced it has obtained an  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics to Announce Fiscal 2012 Second Quarter Results on Tuesday, January 31, 2012
MYGN  
Linked by GlobeNewswire - January 17, 04:10PM from (www.globenewswire.com)
SALT LAKE CITY, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics to Present at the 30th Annual J.P. Morgan Healthcare Conference
MYGN  
Linked by GlobeNewswire - December 28, 04:15PM from (www.globenewswire.com)
SALT LAKE CITY, Dec. 28, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
MYGN  
Linked by GlobeNewswire - December 09, 08:05AM from (www.globenewswire.com)
SALT LAKE CITY, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics to Present at the 22nd Annual Oppenheimer Healthcare Conference
MYGN  
Linked by GlobeNewswire - December 01, 04:10PM from (www.globenewswire.com)
SALT LAKE CITY, Dec. 1, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark Capone, President,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Myriad Genetics to Attend the 23rd Annual Piper Jaffray Health Care Conference
MYGN  
Linked by GlobeNewswire - November 21, 08:05AM from (www.globenewswire.com)
SALT LAKE CITY, Nov. 21, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it will meet with  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 18



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource